1.Investigation of functional magnetic resonance imaging of brain during hand movement induced by neuromuscular electrical stimulation of healthy young subjects
Chinese Journal of Physical Medicine and Rehabilitation 2009;31(4):249-252
Objective To observe fMRI images of brain during hand movement induced by NMES of healthy young subjects and to explore the possible mechanism of NMES to central nervous system. Methods Six right-handed healthy volunteers including 5 males and 1 female, aged 25.17 ± 3.43 years underwent fMRI scanning while NMES was applied to right wrist extensors to elicit a maximal wrist extension. The parameters of stimulation electric current were: frequency 30 Hz, pulse width 0.2 ms, biphase square wave, on time:off time =2 s:2 s, ramp 1 and the intensity was maximal tolerance by subjects. Functional images were processed using SPM2 software package to obtain the localized information in activated cortex region. Results All of the 6 subjects showed fMRI responses upon NMES. Most of wrist extensor stimulated by NMES was associated with activation of the primary motor cortex ( MI ), pre-motor cortex (PMC), supplementary motor cortex (SMC),primary somatosensory cortex (SI). The functional responses arise not only in contralateral cortex, but also in ipsilateral cortex to the stimulated hand movement. Conclusion Wrist exten- tion elicited by NMES can evoke fMRI responses in motor cortex and somatosensory cortex in healthy subjects.
2.Clinical application of percutaneous needling lung abscess drairnage under CT guidance
Xiaokun HU ; Mingyou WANG ; Zhengyu JIN
Journal of Interventional Radiology 1994;0(04):-
Objective To discuss the clinical application of drainage for lung abscess by needle puncture under CT guidance. Methods 18 cases of lung abscess were drainaged by needle puncture under CT guidance, including direct aspiration by puncture needle 1-3 times (n=8) and retaining drainage tube continuously (n=10). Results 17 cases with this procedure were succeeded possessing success rate of 94.7%(17/18). The patients were followed up for 11-35 days with symptom relieving better obviously and the focus shrinkage or disappeared (n=16), the curative rate reached 88.9%(16/18). The main complication was pneumothorax with capacities of %(n=1).Conclusions The curative course of lung abscess can be shortened greatly by percutaneous needling drainage under CT guidance with mild trauma. The procedure is simple with high successful rate and less complication.
3.Inhibitory effects of sinomenine on the activation of nuclear factor-?B and on the degradation of I?B
Xiaokun JIN ; Weidong LI ; Huiling TENG ; Zhibin LIN
Chinese Pharmacological Bulletin 2003;0(07):-
Aim To observe the effect of Sinomenine on the activation of NF-?B and the degradation of its inhibitor I-?B in peritoneal macrophages of BALB/c mice in vitro and provide experimental evidence for further evaluation of the antiinflammatory and antirheumatic effects of Sinomenine. Methods Effect of Sinomenine on the activation of NF-?B p65 in the cells was investigated by using fluorescence-labelling and laser confocal scanning microscopy; Effect of Sinomenine on the degradation of I?B-? was investigated by Western blot. Results SIN (0.25,1.25 mmol?L -1) attenuated the activation of NF-?B p65 in peritoneal macrophages of BALB/c mice induced by LPS in vitro. SIN(0.25,1.25 mmol?L -1) inhibited the degradation of I-?B-? in peritoneal macrophages of BALB/c mice induced by LPS in vitro. Conclusion SIN can partially inhibit the activation of NF-?B p65 and the degradation of I?B-? in peritoneal macrophages of BALB/c mice induced by LPS in vitro.
4.Analysis of 244 ADR Cases in Beijing Tongren Hospital in 2005
Xiaokun JIN ; Chiying XIU ; Huanyu ZHAO ; Li WEN
China Pharmacy 1991;0(05):-
OBJECTIVE:To investigate the characteristics of adverse drug reactions(ADR) in our hospital so as to promote rational clinical drug use.METHODS:244 ADR cases collected in 2005 in our hospital were analyzed retrospectively.RESUL TS:Among the 244 cases,the female exceeded the male;79.83% of the patients were more than 40 years old.The cardiovascular system medicines took the lead which amounted to 45.69% of the total,then came the antimicrobial medicines.The intravenous administration caused most of ADRs.Alprostadil Injection accounted for 9.02% of the total, the highest.Skin and its appendages impairment cases took the biggest percentage at 28.14%.CONCLUSION:we should pay more attention to the ADR monitoring and the spread of ADR knowledge and enhance the ADR awareness of medical staff.sen or avoid the occurrence of ADR,monitoring of which and publicizing of ADR knowledge should be emphasized.
5.Predicting respiratory motion using an Informer deep learning network
Guodong JIN ; Yuxiang LIU ; Bining YANG ; Ran WEI ; Xinyuan CHEN ; Xiaokun LIANG ; Hong QUAN ; Kuo MEN ; Jianrong DAI
Chinese Journal of Radiological Medicine and Protection 2023;43(7):513-517
Objective:To investigate a time series deep learning model for respiratory motion prediction.Methods:Eighty pieces of respiratory motion data from lung cancer patients were used in this study. They were divided into a training set and a test set at a ratio of 8∶2. The Informer deep learning network was employed to predict the respiratory motions with a latency of about 600 ms. The model performance was evaluated based on normalized root mean square errors (nRMSEs) and relative root mean square errors (rRMSEs).Results:The Informer model outperformed the conventional multilayer perceptron (MLP) and long short-term memory (LSTM) models. The Informer model yielded an average nRMSE and rRMSE of 0.270 and 0.365, respectively, at a prediction time of 423 ms, and 0.380 and 0.379, respectively, at a prediction time of 615 ms.Conclusions:The Informer model performs well in the case of a longer prediction time and has potential application value for improving the effects of the real-time tracking technology.
6.Diagnosis and treatment of arrhythmogenic cardiomyopathy in children
Wenqian YE ; Yanyan XIAO ; Xiaokun JIANG ; Mei JIN ; Xiaofang WANG ; Wenhong DING
Chinese Journal of Pediatrics 2024;62(4):363-367
Objective:To summarize the clinical manifestations, experiences in diagnosis and treatment of arrhythmogenic cardiomyopathy (ACM) in children.Methods:A retrospective analysis of the clinical manifestations, laboratory tests, radiological features, treatment and follow-up results was conducted in 11 children diagnosed with ACM at the center of congenital heart disease, Beijing anzhen hospital from May 2010 to March 2022.Results:A total of 11 patients aged 2 to 16 years, including 5 males and 6 females were diagnosed with ACM. The clinical manifestations included decreased activity tolerance (7 patients), heart failure (4 patients), syncope or sudden death (3 patients), palpitation (3 patients), and chest tightness and pain (3 patients). Electrocardiogram showed right bundle branch block in 9 cases, paroxysmal ventricular tachycardia in 4 cases, frequent premature ventricular contraction in 4 cases, ventricular pre-excitation in 1 case, left bundle branch block in 1 case, and first degree atrioventricular block in 2 cases. Echocardiography showed enlargement of the right heart, widening of the right ventricular outflow tract, and thinning and bulging of the local wall of the right ventricle with reduced pulsation. Ventricular thrombosis was found in 2 cases. Six children underwent cardiac magnetic resonance imaging, which mainly showed severe enlargement of the right heart, thin free wall of the right ventricle, decreased right heart function, enhanced right ventricular myocardium, and formation of right ventricular aneurysm. Two children underwent myocardial biopsy examination and presented with typical pathological changes of ACM. Genetic tests in five patients revealed DSG2 gene mutation in 2 cases, PKP2 gene mutation in 2 cases, and MYH6 gene mutation in 1 case. All patients received anti heart failure treatment and antiarrhythmic drugs. Two children received anticoagulant treatment due to ventricular thrombosis. Radiofrequency ablation was performed in 2 patients. Glenn procedure was performed in 4 patients, and heart transplantation was performed in 1 patient due to progressive heart failure. The follow-up period ranged from 6 months to 12 years. Two cases died of right heart failure, 6 cases had different degrees of heart failure, 1 case had intermittent chest tightness and pain, and 2 cases were stable.Conclusions:ACM is a progressive genetic cardiomyopathy characterized by decreased activity tolerance, cardiac failure and arrhythmia in pediatric patients. The diagnosis is mainly based on clinical manifestations, electrocardiogram, cardiac imaging changes, and genetic testing. Early detection, diagnosis, and personalized treatment can improve the prognosis.
7.Evidence for lung repair and regeneration in humans: key stem cells and therapeutic functions of fibroblast growth factors.
Xuran CHU ; Chengshui CHEN ; Chaolei CHEN ; Jin-San ZHANG ; Saverio BELLUSCI ; Xiaokun LI
Frontiers of Medicine 2020;14(3):262-272
Regeneration carries the idea of regrowing partially or completely a missing organ. Repair, on the other hand, allows restoring the function of an existing but failing organ. The recognition that human lungs can both repair and regenerate is quite novel, the concept has not been widely used to treat patients. We present evidence that the human adult lung does repair and regenerate and introduce different ways to harness this power. Various types of lung stem cells are capable of proliferating and differentiating upon injury driving the repair/regeneration process. Injury models, primarily in mice, combined with lineage tracing studies, have allowed the identification of these important cells. Some of these cells, such as basal cells, broncho-alveolar stem cells, and alveolar type 2 cells, rely on fibroblast growth factor (FGF) signaling for their survival, proliferation and/or differentiation. While preclinical studies have shown the therapeutic benefits of FGFs, a recent clinical trial for acute respiratory distress syndrome (ARDS) using intravenous injection of FGF7 did not report the expected beneficial effects. We discuss the potential reasons for these negative results and propose the rationale for new approaches for future clinical trials, such as delivery of FGFs to the damaged lungs through efficient inhalation systems, which may be more promising than systemic exposure to FGFs. While this change in the administration route presents a challenge, the therapeutic promises displayed by FGFs are worth the effort.